- August 1, 2025 (Q2 Earnings): Stock dipped slightly post-report but rebounded within days.
- Previous Quarters: Mixed reactions—some reports led to short-term dips, while others sparked rallies.
How to Buy Moderna, Inc. (MRNA) Shares - Investment in Moderna, Inc. (MRNA) Stock
Updated on 19 Aug 2025
Thinking about adding a biotech powerhouse to your portfolio? Moderna, Inc. (MRNA) is more than just a COVID-19 vaccine maker—it’s a pioneer in mRNA technology with a pipeline full of potential. Whether you're a newbie or a seasoned trader, this breakdown will help you navigate MRNA’s stock like a pro.
Article navigation
📈 Moderna Stock: Price, Trends, and What’s Next
Current Price (August 19, 2025)
As of today, Moderna (MRNA) is trading at $28.09 (Macrotrends). That’s a far cry from its all-time high of $497.49 in 2021, but the stock has shown resilience recently, gaining 9.30% over the last four weeks (Trading Economics).
Mark Your Calendar: November 6, 2025
The next big date for MRNA investors is November 6, 2025, when the company releases its Q3 earnings report. Historically, earnings announcements have caused significant price swings. For example:
6-Month Price Journey (February-August 2025)
Here’s how MRNA has moved over the past half-year:
- February 2025: Around $35 (post-earnings dip).
- April 2025: Dropped to $25 amid regulatory uncertainty.
- June 2025: Climbed to $30 on positive clinical trial news.
- August 2025: Stabilized near $28.
Why the volatility?
- Declining COVID-19 vaccine sales.
- Shifting focus to cancer treatments and other mRNA therapies.
- Legal wins (like the UK patent victory over Pfizer/BioNTech) boosting investor confidence (Nasdaq).
🔮 Price Forecast: 2025-2030
Analysts are divided on MRNA’s future, but here’s a snapshot of predictions:
- 2025: Could range from $37.93 to $255.33 (Stockscan).
- 2026: Bullish forecasts suggest $250 if mRNA cancer trials succeed (CoinPriceForecast).
- 2028: Potential to hit $350 with expanded therapeutic applications.
- 2030: Optimistic targets place MRNA at $450+ if it dominates mRNA medicine.
Verdict: A high-risk, high-reward play. Consider dollar-cost averaging to mitigate volatility.
⚠️ Key Risks vs. Positive Signals
Risks to Watch
- Regulation Shifts: Federal funding cuts for mRNA research (Morningstar).
- Pipeline Delays: Clinical trials take time—setbacks could hurt the stock.
- Competition: Pfizer and BioNTech are still in the mRNA race.
Green Lights for 2025
- Legal Wins: Patent victories strengthen Moderna’s market position.
- Pipeline Growth: 45 programs in development, including cancer treatments (LiteFinance).
- Industry Trend: mRNA tech is expanding beyond vaccines—think cancer, rare diseases, and more.
🛡️ What Should a Beginner Trader Do Today?
- Start Small: Buy fractional shares to test the waters.
- Watch Earnings: November 6 could be a make-or-break moment.
- Diversify: Don’t put all your eggs in the biotech basket.
- Humorous Take: “Trading MRNA is like dating a scientist—exciting but unpredictable. Don’t propose on the first date!”
✅ How to Buy Moderna, Inc. (MRNA) Shares – Step by Step
| Step | Action | Why It Matters |
|---|---|---|
| 1 | Choose a trading platform | Ensure it supports NASDAQ-listed stocks like MRNA. |
| 2 | Fund your account | Even $50 can get you started with fractional shares. |
| 3 | Search for “MRNA” | Use the ticker, not just “Moderna.” |
| 4 | Place a limit order | Set your max price (e.g., $28) to avoid overpaying. |
| 5 | Confirm & monitor | Track news and earnings reports for timing exits or adding more. |
💡 Why Pocket Option Fits New Investors
Pocket Option makes trading accessible:
- Minimum deposit: $5—perfect for beginners.
- Quick KYC: Verify with just one document and start trading fast.
- Flexible withdrawals: Crypto, e-wallets, and more.
🌍 Moderna in 2025: Beyond Vaccines
Moderna is pivoting from COVID-19 to groundbreaking mRNA therapies for cancer, rare diseases, and autoimmune disorders. Fun fact: In 2025, Moderna’s labs started using AI to design personalized mRNA treatments—imagine a vaccine tailored just for you!
FAQ
Is Moderna a good long-term investment?
It depends on their pipeline success. High risk but high potential reward.
When is the best time to buy MRNA stock?
After earnings dips or positive clinical trial announcements.
What’s the biggest risk for Moderna?
Over-reliance on mRNA tech without diversification.
Can I trade MRNA on Pocket Option?
Yes! Pocket Option offers quick trading with low barriers to entry.
What’s Moderna’s most exciting project?
Their mRNA-based cancer vaccines—could be a game-changer.
Signals
Sign up for more like this
Customize your newsfeed with content you're actually interested in — get up-to-date personalized newsletter in your inbox.
Your comment
Comments are pre-moderated to ensure they comply with our blog guidelines.